Homeostasis

Jun 01, 2020

Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19

May 15, 2020

Proteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Dec 03, 2019

Proteostasis Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare Conference

Dec 02, 2019

Proteostasis Therapeutics Regains Compliance with Nasdaq Listing Standards

Sep 19, 2019

Proteostasis Therapeutics Announces Presentation at the UK Cystic Fibrosis Conference

Jul 23, 2019

Proteostasis Therapeutics Announces Management Changes and Appointments

May 15, 2019

Proteostasis Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference

Mar 07, 2019

Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors

Dec 20, 2018

Proteostasis Therapeutics Provides Clinical Enrollment Update

Dec 17, 2018

Proteostasis Therapeutics Announces Global License Agreement with Genentech

Oct 22, 2018

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

Sep 27, 2018

Proteostasis Therapeutics to Present at the Cantor Global Healthcare Conference

Jun 25, 2018

Proteostasis Added to the Russell 3000® Index

May 31, 2018

Proteostasis Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

Mar 19, 2018

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock